EUVIMEDEUVIMED entdecken
Crossref

The impact of periodontal therapy on clinical and inflammatory parameters in type II diabetics

Julie Tokatlian, Mohanad Al-Sabbagh, Dolphus R Dawson, Kevin A Pearce, M Oelisoa Andriankaja, Reuben Adatorwovor, Manuela Maria Viana Miguel, Luciana Macchion Shaddox

Journal of Periodontology · 2026

DOI: 10.1002/jper.70035 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Periodontology, 2026. Verfasst von Julie Tokatlian und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral Health Practice, Periodontology Division, College of Dentistry, University of Kentucky, Lexington, Kentucky, USA. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Inflammation Mediators, Chronic Periodontitis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: Colgate Palmolive Grant.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

An association between periodontal disease and diabetes exists, although the mechanisms associated with treatment response and glycemic control are not fully elucidated. The goals of this study were to evaluate the clinical response, local (gingival crevicular fluid – GCF) and systemic (serum) inflammatory and metabolic profile following periodontal treatment of type II diabetic subjects.

Methods

Forty‐two type II diabetic subjects with hemoglobin A1C (HbA1c) > 6.5 and periodontitis were evaluated following non‐surgical periodontal treatment. Periodontal parameters (e.g., pocket depth – PD, clinical attachment level – CAL, and bleeding on probing – BoP), HbA1c, local and systemic inflammatory mediators were evaluated at baseline, 3, 6, and 12 months.

Results

All periodontal parameters were reduced post‐treatment ( p < 0.001). Although HbA1c levels were not reduced post‐treatment ( p = 0.515), they were positively associated with baseline PD > 4 mm and BoP as well as with PD/CAL and PD > 4 mm reductions. Both local and systemic inflammatory profiles were modulated post‐treatment ( p < 0.05), with local reductions of INF‐γ, IL‐10, IL‐12p40, MIP‐1α, and GM‐CSF at 3 months ( p < 0.05), and systemic Eotaxin at 12 months. Other systemic markers increased post‐treatment. HbA1c was associated with local IL‐1β and systemic Eotaxin reductions ( p < 0.05).

Conclusions

Uncontrolled diabetic subjects showed a positive clinical response and differentiated local and systemic profile post‐treatment, where local markers were reduced in the short‐term and several systemic markers increased. Although HbA1c was not reduced post‐treatment, it was associated with clinical and some inflammatory response. ClinicalTrials.gov ID NCT01881074.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Inflammation MediatorsChronic PeriodontitisHumansGlycated HemoglobinFemaleMaleMiddle AgedGingival Crevicular FluidInterleukin-10Periodontal Attachment LossPeriodontal IndexChemokine CCL3Follow-Up StudiesInterleukin-12 Subunit p40Interferon-gammaPeriodontal PocketChemokine CCL11Granulocyte-Macrophage Colony-Stimulating FactorInterleukin-1betaAgedAdultDental Scaling

Stichwörter der Autor:innen

biomarkersdental scalingdiabetes mellitusglycemic controlhemoglobin A1c protein, humanperiodontal diseases

Substanzen

Glycated HemoglobinInflammation MediatorsInterleukin-10Chemokine CCL3Interleukin-12 Subunit p40Interferon-gammaChemokine CCL11Granulocyte-Macrophage Colony-Stimulating FactorInterleukin-1betaIL10 protein, human

Autor:innen und Institutionen

  • Department of Oral Health Practice, Periodontology Division, College of Dentistry, University of Kentucky, Lexington, Kentucky, USA.
  • Department of Family and Community Medicine, College of Medicine, Division of Primary Care, University of Kentucky, Lexington, Kentucky, USA.
  • Center for Oral Health Research, College of Dentistry, University of Kentucky, Lexington, Kentucky, USA.
  • Department of Biostatistics, College of Public Health, University of Kentucky, Lexington, Kentucky, USA.

Förderung

  • Colgate Palmolive Grant

Zitieren

APA

Tokatlian, J., Al-Sabbagh, M., Dawson, D. R., Pearce, K. A., Andriankaja, M. O., Adatorwovor, R., Miguel, M. M. V., & Shaddox, L. M. (2026). The impact of periodontal therapy on clinical and inflammatory parameters in type II diabetics. Journal of Periodontology. https://doi.org/10.1002/jper.70035

Vancouver

Tokatlian J, Al-Sabbagh M, Dawson DR, Pearce KA, Andriankaja MO, Adatorwovor R, et al. The impact of periodontal therapy on clinical and inflammatory parameters in type II diabetics. Journal of Periodontology. 2026. doi:10.1002/jper.70035

BibTeX
@article{Tokatlian2026,
  author = {Tokatlian, Julie and Al-Sabbagh, Mohanad and Dawson, Dolphus R and Pearce, Kevin A and Andriankaja, M Oelisoa and Adatorwovor, Reuben and Miguel, Manuela Maria Viana and Shaddox, Luciana Macchion},
  title = {The impact of periodontal therapy on clinical and inflammatory parameters in type II diabetics},
  journal = {Journal of Periodontology},
  year = {2026},
  doi = {10.1002/jper.70035}
}
Kostenlos starten →